PRTA FY 2023 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$91M+69.5% YoY

Gross Profit

$91M100.0% margin

Operating Income

-$191M-209.1% margin

Net Income

-$147M-160.9% margin

EPS (Diluted)

$-2.76

Cash Flow

Operating Cash Flow

-$134M

Free Cash Flow

-$137M

Stock-Based Comp.

$41M

Balance Sheet

Total Assets

$696M

Total Liabilities

$135M

Stockholders' Equity

$561M

Cash & Equivalents

$619M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$91M	$54M	+69.5%
Gross Profit	$91M	$54M	+69.5%
Operating Income	-$191M	-$132M	-45.2%
Net Income	-$147M	-$117M	-25.7%